Cocaine effects on pulsatile secretion of ACTH in men. 1994

S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
Endocrine Unit, Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts.

The effects of cocaine on pulsatile secretion of adrenocorticotropic hormone (ACTH) in men were studied under controlled clinical research ward conditions. Eight men with a Diagnostic and Statistical Manual of the American Psychiatric Association Version III, revised, diagnosis of concurrent cocaine and opioid dependence provided their informed consent for participation in this study. After an overnight fast, a challenge dose of cocaine (30 mg i.v.) or placebo was administered under single-blind conditions in a randomized order on 2 study days. Blood samples were collected at 2-min intervals for 76 min during base line and for an additional 76 min after i.v. administration of the challenge dose. Peak plasma cocaine levels of 313.8 +/- 46.5 ng/ml were detected within 2 min after cocaine administration. The cluster analysis program originally described by Veldhuis and Johnson (1986) was used to characterize ACTH pulsatile secretion (Iranmanesh et al., 1990). Acute cocaine administration (30 mg i.v.) significantly increased ACTH mean peak amplitude (P < .05), mean percent increase in peak amplitude, (P < .05), mean peak area (P < .04), total peak area (P < .04) and incremental peak height (P < .04). Mean ACTH valley levels (P < .02) and mean valley nadir (P < .02) were also significantly increased after cocaine administration. We postulate that cocaine stimulates the release of corticotropin releasing factor and that the cocaine-induced secretion of corticotropin releasing factor increases the amplitude of ACTH pulses, because ACTH pulse frequency was not altered by cocaine.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011673 Pulsatile Flow Rhythmic, intermittent propagation of a fluid through a BLOOD VESSEL or piping system, in contrast to constant, smooth propagation, which produces laminar flow. Flow, Pulsating,Perfusion, Pulsatile,Flow, Pulsatile,Flows, Pulsatile,Flows, Pulsating,Perfusions, Pulsatile,Pulsatile Flows,Pulsatile Perfusion,Pulsatile Perfusions,Pulsating Flow,Pulsating Flows
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016037 Single-Blind Method A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned. Single-Masked Study,Single-Blind Study,Single-Masked Method,Method, Single-Blind,Method, Single-Masked,Methods, Single-Blind,Methods, Single-Masked,Single Blind Method,Single Blind Study,Single Masked Method,Single Masked Study,Single-Blind Methods,Single-Blind Studies,Single-Masked Methods,Single-Masked Studies,Studies, Single-Blind,Studies, Single-Masked,Study, Single-Blind,Study, Single-Masked
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
December 1989, The Journal of clinical endocrinology and metabolism,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
September 1995, The Journal of clinical endocrinology and metabolism,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
May 2014, American journal of physiology. Regulatory, integrative and comparative physiology,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
September 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
December 1975, Acta physiologica Scandinavica,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
April 1994, Molecular and cellular neurosciences,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
January 1998, Journal of the Society for Gynecologic Investigation,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
January 1997, The Journal of endocrinology,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
May 1994, The Journal of clinical endocrinology and metabolism,
S K Teoh, and Z Sarnyai, and J H Mendelson, and N K Mello, and S A Springer, and J W Sholar, and M Wapler, and J C Kuehnle, and H Gelles
January 1994, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!